This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Johns Hopkins University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Malcolm V Brock: Innovator in Cancer Biology
Introduction
Malcolm V Brock is a prominent inventor based in Owings Mills, MD (US). He has made significant contributions to the field of cancer biology through his innovative research and patented inventions. His work focuses on the detection of nucleic acid hypermethylation, which plays a crucial role in identifying metastases and predicting disease recurrence.
Latest Patents
Malcolm V Brock holds 1 patent for his invention titled "DNA methylation markers and methods of use." This patent provides methods for identifying metastases by detecting nucleic acid hypermethylation of one or more genes in various samples, particularly in lymph nodes. The invention also relates to using DNA methylation as a predictor of disease recurrence and patient prognosis, specifically in cancer biology.
Career Highlights
Brock is affiliated with Johns Hopkins University, where he continues to advance research in cancer biology. His work has garnered attention for its potential to improve patient outcomes through early detection and better understanding of cancer progression.
Collaborations
Some of his notable coworkers include Stephen B Baylin and James Gordon Herman, who have also contributed to the field of cancer research.
Conclusion
Malcolm V Brock's innovative work in cancer biology, particularly through his patented methods for detecting DNA methylation, highlights the importance of research in improving cancer diagnosis and treatment. His contributions continue to influence the field and offer hope for better patient prognoses.